Gene · 4938
Papers3,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rescue of a unique ovine parainfluenza virus type 3 strain via Red/ET assembly. | Microb Pathog | 2025 | 40147559 | PubTator, text mining | PubMed |
| Processing of genomic RNAs by Dicer in bat cells limits SARS-CoV-2 replication. | Virol J | 2025 | 40133950 | PubTator, text mining | PubMed |
| Distinct pathogenic mutations in ARF1 allow dissection of its dual role in cGAS-STING signalling. | EMBO Rep | 2025 | 40128408 | PubTator, text mining | PubMed |
| Mpox virus poxin-schlafen fusion protein suppresses innate antiviral response by sequestering STAT2. | Emerg Microbes Infect | 2025 | 40066622 | PubTator, text mining | PubMed |
| The influence of genetic polymorphisms on cytokine profiles in pediatric COVID-19: a pilot study. | Front Pediatr | 2025 | 40066463 | PubTator, text mining | PubMed |
| Rhinoviral Infection of the Human Lung Vascular Endothelium May Protect From the Secondary Infection With Rhinovirus RV-16. | APMIS | 2025 | 40051189 | PubTator, text mining | PubMed |
| Switching of OAS1 splicing isoforms overcomes SNP-derived vulnerability to SARS-CoV-2 infection. | BMC Biol | 2025 | 40025489 | PubTator, text mining | PubMed |
| A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatment. | Cancer Lett | 2025 | 40021042 | PubTator, text mining | PubMed |
| OAS cross-activates RNase L intercellularly through cell-to-cell transfer of 2-5A to spread innate immunity. | Immunity | 2025 | 40010341 | Swiss-Prot, curated | PubMed |
| Classical Swine Fever Virus Envelope Glycoproteins Erns, E1, and E2 Activate IL-10-STAT1-MX1/OAS1 Antiviral Pathway via Replacing Classical IFNα/β. | Biomolecules | 2025 | 40001503 | PubTator, text mining | PubMed |
| The African swine fever virus gene MGF_360-4L inhibits interferon signaling by recruiting mitochondrial selective autophagy receptor SQSTM1 degrading MDA5 antagonizing innate immune responses. | mBio | 2025 | 39998221 | PubTator, text mining | PubMed |
| Autoinflammatory encephalopathy due to PTPN1 haploinsufficiency: a case series. | Lancet Neurol | 2025 | 39986310 | PubTator, text mining | PubMed |
| Robust antiviral innate immune response and miRNA regulatory network were identified in ZIKV-infected cells: implications in the pathogenesis of ZIKV infection. | Virus Genes | 2025 | 39955676 | PubTator, text mining | PubMed |
| The role of candidate genetic polymorphisms in covid-19 susceptibility and outcomes. | BMC Med Genomics | 2025 | 39920651 | PubTator, text mining | PubMed |
| OAS1: A Protective Mechanism for Alzheimer's Disease? An Exploration of Data and Possible Mechanisms. | Int J Mol Sci | 2025 | 39859237 | PubTator, text mining | PubMed |
| Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes. | Biomolecules | 2025 | 39858451 | PubTator, text mining | PubMed |
| Correction: Integrated Mendelian randomization and single-cell RNA-sequencing analyses identified OAS1 as a novel therapeutic target for erectile dysfunction via targeting fibroblasts. | Biol Direct | 2025 | 39849574 | PubTator, text mining | PubMed |
| Baricitinib Treatment in RNU7-1-Associated Aicardi-Goutières Syndrome in a South African Child: A Case Report. | Am J Med Genet A | 2025 | 39748568 | PubTator, text mining | PubMed |
| OAS1 induces endothelial dysfunction and promotes monocyte adhesion through the NFκB pathway in atherosclerosis. | Arch Biochem Biophys | 2025 | 39571957 | PubTator, text mining | PubMed |
| Weighted Gene Co-expression Network Analysis and Machine Learning Validation for Identifying Major Genes Related to Sjogren's Syndrome. | Biochem Genet | 2025 | 38678487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4938/papers?page=8